ArticleBMC urology2025

Comparative real-world study of apalutamide and darolutamide in Japanese patients with non-metastatic castration-resistant prostate cancer.

Maiko Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.